Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/14/2007EP1495018B1 Tricyclic thrombin receptor antagonists
11/14/2007EP1480654A4 Carbohydrate-based anti-wrinkle and tissue remodelling compounds
11/14/2007EP1476158B1 Nicotinamide derivatives useful as pde4 inhibitors
11/14/2007EP1469835B1 Stable salts of o-acetylsalicylic acid containing basic amino acids ii
11/14/2007EP1427722B1 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression
11/14/2007EP1413309B1 Drugs for ameliorating postcibal hyperglycemia
11/14/2007EP1411064B1 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
11/14/2007EP1409480B1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment
11/14/2007EP1409021B1 Formulation comprising fulvestrant
11/14/2007EP1399423B1 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds
11/14/2007EP1393637B1 Use of palatinose for sustaining mental concentration and attentiveness
11/14/2007EP1383507B1 Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances
11/14/2007EP1381355B1 Use of rhein and its derivatives as matrix metalloproteinase inhibitors
11/14/2007EP1370264B1 Nicotinic receptor agonists for the treatment of pulmonary inflammatory diseases
11/14/2007EP1368048B1 Pharmaceutical composition made of cannabis extracts
11/14/2007EP1368021B1 Carbamate compounds for use in preventing or treating bipolar disorder
11/14/2007EP1362053B1 Terminally-branched polymeric linkers and polymeric conjugates containing the same
11/14/2007EP1332145B1 Process for formulation of antibiotic compounds
11/14/2007EP1322655B1 Oligodeoxynucleotide and its use to induce an immune response
11/14/2007EP1317238B1 Compositions containing a vitamin c component and pigment
11/14/2007EP1296651B1 Method of making particles for use in a pharmaceutical composition
11/14/2007EP1254239B1 Mammalian secreted group iii phospholipase a2
11/14/2007EP1244435B1 Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
11/14/2007EP1237536B1 The use of fluorescent whitening agents
11/14/2007EP1212086B1 Immunological tolerance-induction agent
11/14/2007EP1210462B1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications
11/14/2007EP1185269B1 Glycosyltransferase inhibitors
11/14/2007EP1181042B1 Neurotrophic factors in the treatment of peripheral nerve dysfunction of pelvic area
11/14/2007EP1141079B1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties
11/14/2007EP1121930B1 Drug preparation "histochrome" for treating acute myocardial infarction and ischaemic heart diseases
11/14/2007EP1121454B1 Extracellular novel rage binding protein (en-rage) and uses thereof
11/14/2007EP1104765B2 Process for preparing n,n,6- trimethyl-2 -(4-methylphenyl)- imidazo-[1,2-a] -pyridine-3- acetamide and salts thereof
11/14/2007EP1102593B1 Prostate formula
11/14/2007EP1091735B1 Improved enriched platelet wound healant
11/14/2007EP1034189B1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
11/14/2007EP1003783B1 Lipoprotein-regulating medicaments
11/14/2007EP0990654B1 Substituted cyclobutylamine derivatives
11/14/2007EP0960937B1 Novel semaphorin gene: semaphorin y
11/14/2007EP0959792B1 Spine distraction implant
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007CN101072875A Novel cancer antigen peptide and the use thereof
11/14/2007CN101072815A Polymeric polphenol extracted for fermented tea, therapeutic agent for mitochondrial disease, preventive/therapeutic agent for diabetes mellitus, and food or beverage
11/14/2007CN101072792A Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal
11/14/2007CN101072787A Substituted adenines and the use thereof
11/14/2007CN101072784A Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them
11/14/2007CN101072783A Phosphonic acid derivative and therapeutic agent for disease in which high phosphate level in blood participates
11/14/2007CN101072781A Macrocyclic quinazoline derivatives and their use as mtki
11/14/2007CN101072780A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/14/2007CN101072779A 2,4 (4,6) pyrimidine derivatives
11/14/2007CN101072778A Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
11/14/2007CN101072776A Novel diazabicyclononene derivative
11/14/2007CN101072775A Novel mch receptor antagonists
11/14/2007CN101072774A Enantiomers of 3-heteroaryl-8h-8-azabicyclo(3.2.1)oct-2-ene and their use as monoamine neurotransmitter re-uptake inhibitors
11/14/2007CN101072773A Pyrrole derivatives having CRTH2 receptor antagonist activity
11/14/2007CN101072772A 凝血酶受体拮抗剂 Thrombin receptor antagonists
11/14/2007CN101072771A Cgrp受体拮抗剂 Cgrp receptor antagonists
11/14/2007CN101072770A Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sites
11/14/2007CN101072769A Antiplatelet agent and process for producing the same
11/14/2007CN101072768A 5-sulfonyl-1-piperidinyl substituted indole derivatives as 5-ht6 receptor antagonists for the treatment of CNS disorders
11/14/2007CN101072765A Phenylpiperazines with a combination of affinity for dopamine -D2 receptors and serotonin reuptake sites
11/14/2007CN101072762A Phenyl-piperazin methanone derivatives
11/14/2007CN101072760A Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
11/14/2007CN101072759A Triazole compounds that modulate hsp90 activity
11/14/2007CN101072758A 喹唑啉衍生物 Quinazoline derivatives
11/14/2007CN101072757A Benzamide derivatives that act upon the glucokinase enzyme
11/14/2007CN101072753A Process for the preparation of carvedilol and its enantiomers
11/14/2007CN101072752A Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same
11/14/2007CN101072590A Dmbt1 as a clinical marker and uses thereof
11/14/2007CN101072588A Liposomes with improved drug retention for treatment of cancer
11/14/2007CN101072575A Hcv ns3-ns4a protease inhibition
11/14/2007CN101072573A Bacterial compositions for prevention or treatment of atherosclerotic disorders
11/14/2007CN101072570A Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
11/14/2007CN101072569A Compositions containing uridine, and methods utilizing same
11/14/2007CN101072568A Product containing prostaglandin having fluorine atom in molecule
11/14/2007CN101072567A Ready-for-use injectable solution of 9-((1,3-dihydroxypropan-2-iloxy)methyl)-2-amine-1h-purin-6(9h)-one
11/14/2007CN101072566A Pharmaceutical compositions for transdermal delivery
11/14/2007CN101072565A Method and composition for supplementation of nutritional deficiencies in renal patients
11/14/2007CN101072564A Endothelin a receptor (eta) antagonists in combination with phosphodiesterase 5 inhibitors (pde5) and uses thereof
11/14/2007CN101072563A Benzdioxane piperazine derivatives with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites
11/14/2007CN101072562A Use ranolazone in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
11/14/2007CN101072561A Diaminoalkane aspartic protease inhibitors
11/14/2007CN101072560A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072559A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072558A Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition
11/14/2007CN101072557A Use of PPAR agonists for the treatment of congestive heart failure
11/14/2007CN101072556A Triazoles useful as inhibitors of protein kinases
11/14/2007CN101072555A Methods, assays and compositions for treating retinol-related diseases
11/14/2007CN101072554A Therapeutic treatment of accelerated bone resorption
11/14/2007CN101072547A Delivery system for topical medications
11/14/2007CN101072509A Treatment and prevention of inflammatory disorders
11/14/2007CN101072504A Methods and compositions for treating chronic lymphocytic leukemia
11/14/2007CN101070552A Use of krev alcohol in preparing tyrosinase inhibitor
11/14/2007CN101070551A Use of krev alcohol in preparing antioxidation agent
11/14/2007CN101070550A Method for preparing krev alcohol and use for preparing anti-acetylcholinesterase medicine
11/14/2007CN101070355A Amphoteric konnijaku glucomannan humidity retaining agent and preparing method
11/14/2007CN101070354A Method for synchronous producing aloe polysaccharide powder and aloe active water using aloes
11/14/2007CN101070338A Tanshinone IIA potassium sulfonate used for preparing medicine for preventing and treating cerebral ischemia and cerebral anoxia and myocardial ischemia and myocardio anoxia
11/14/2007CN101070337A Tubeimuside and bile acid derivative and their medicine composition
11/14/2007CN101070328A (E)3,5-di-methoxy-diphenylene-4'-0-phosphates (salt) and its preparing method, medicine composition and use
1 ... 3505 3506 3507 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 3519 3520 3521 3522 3523 3524 3525 ... 7860